Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
Text Size
3 studies found for:    2695141 [PUBMED-IDS]

Modify this search | How to Use Search Results

Show Display Options
Rank Status Study
1 Terminated Study of the Effects of Glycine on Symptoms and Memory in Patients With Schizophrenia
Conditions: Schizophrenia;   Schizoaffective Disorder
Interventions: Dietary Supplement: Glycine;   Dietary Supplement: Placebo
2 Completed A Comparison of Two Cognitive Batteries in People With Schizophrenia
Conditions: Schizophrenia;   Schizoaffective Disorder
Interventions: Other: CDR Computerized Cognitive Assessment System;   Other: MATRICS Consensus Cognitive Battery
3 Unknown † Genetic Expression in Schizophrenics Treated With SSRI Augmentation: Relationship to Clinical and Cognitive Function
Condition: Schizophrenia
Intervention: Drug: Fluvoxamine
To Top

† Indicates status has not been verified in more than two years